Effect of combined treatment with rosiglitazone and body weight control on the patients with impaired glucose tolerance / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
;
(12): 143-144, 2008.
Artigo
em Chinês
| WPRIM
| ID: wpr-401594
ABSTRACT
After treatment for 3 months in the patients with impaired glucose tolerance (IGT), plasma glucose, insulin and homeostasis model assessment for insulin resistance (HOMA-IR) were decreased both in rosiglitazone therapy group and in the group treated with rosiglitazone combined with body weight control.Those parameters in the latter group were decreased more significantly than those in the former.Rosiglitazone ameliorates the insulin resistance in patients with IGT, which is further improved when combined with body weight control.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Chinese Journal of Endocrinology and Metabolism
Ano de publicação:
2008
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS